SC-66

CAS No. 871361-88-5

SC-66( SC66 | SC 66 )

Catalog No. M16333 CAS No. 871361-88-5

SC66 is an allosteric Akt inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 38 In Stock
10MG 53 In Stock
25MG 92 In Stock
50MG 141 In Stock
100MG 206 In Stock
200MG Get Quote In Stock
500MG 513 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SC-66
  • Note
    Research use only, not for human use.
  • Brief Description
    SC66 is an allosteric Akt inhibitor.
  • Description
    SC66 is an allosteric Akt inhibitor; exhibits a dual inhibitory activity that directly interferes with the PH domain binding to PIP3 and facilitates Akt ubiquitination; has anticancer activity mouse xenograft tumor model.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    SC66 | SC 66
  • Pathway
    Cytoskeleton/Cell Adhesion Molecules
  • Target
    Akt
  • Recptor
    Akt
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    871361-88-5
  • Formula Weight
    276.3324
  • Molecular Formula
    C18H16N2O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 34 mg/mL
  • SMILES
    O=C1/C(CCC/C1=C\C2=CC=NC=C2)=C/C3=CC=NC=C3
  • Chemical Name
    Cyclohexanone, 2,6-bis(4-pyridinylmethylene)-, (2E,6E)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Jo H, et al. Proc Natl Acad Sci U S A. 2011 Apr 19;108(16):6486-91. 2. Cusimano A, et al. Oncotarget. 2015 Jan 30;6(3):1707-22.
molnova catalog
related products
  • Crosstide

    Crosstide is a peptide analog of glycogen synthase kinase-3 (GSK-3) that functions as a natural substrate for Akt/PKB.

  • Ipatasertib dihydroc...

    Ipatasertib dihydrochloride is a highly selective and ATP-competitive inhibitor of pan-Akt (IC50s: 5, 18 and 8 nM for Akt1, Akt2 and Akt3, respectively).

  • Marein

    Marein shows neuroprotective effect on PC12 cell damage induced by methylglyoxal, which is due to a reduction of damage to mitochondria function and activation of the AMPK signal pathway.